Ad-hoc | 31 October 2006 07:30

Fresenius Medical Care AG & Co. KGaA Reports Third Quarter 2006 Results

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Fresenius Medical Care Reports Third Quarter 2006 Results Net revenue for the third quarter 2006 increased by 30% (29% at constant currency) to $2,234 million. The organic revenue growth worldwide was 10%. Dialysis Services revenue grew by 37% to $1,704 million (36% at constant currency). Dialysis Product revenue increased by 13% to $530 million (11% at constant currency). Operating income (EBIT) increased by 47% to $349 million. Excluding one-time items, operating income for the third quarter 2006 increased by 47% to $358 million. Net income for the third quarter 2006 was $139 million, an increase of 20%. Excluding one-time items, the net income increased by 21% to $145 million. Net revenue for the first nine months 2006 increased by 23% (23% at constant currency) to $6,147 million. Operating income (EBIT) for the nine months ended September 30, 2006 increased by 39% to $964 million. Excluding one-time items, operating income for the nine months ended September 30, 2006 increased by 35% to $946 million. Net income rose by 13% to $385 million in the first nine months of 2006. Excluding one-time items, net income increased by 20% to $412 million. Based on the strong performance in the third quarter of 2006, the Company upgrades its guidance for the full year 2006. After expecting to report net revenue of about $8.3 billion, the Company now expects net revenue for 2006 of about $8.4 billion. The Company also upgrades its outlook for reported net income for 2006. After expecting a net income of at least $542 million, the Company now expects a net income of at least $557 million, representing an increase of at least 18% over the corresponding level in 2005. In order to show the underlying performance of the Company on a basis comparable with the prior year, the guidance does not take into effect any expected one-time items and the change of accounting principle for stock options – SFAS 123(R) in the fiscal year 2006. The Company expects the after tax impact of the one-time items and SFAS 123(R) to be about $44 million for the full year 2006. Fresenius AG (WKN 578560, 578563) holds approximately 37% of Fresenius Medical Care AG & Co. KGaA’s capital. Fresenius Medical Care AG & Co. KGaA, Represented by Fresenius Medical Care Management AG, Board of Management, Bad Homburg v.d.H., October 31, 2006 (c)DGAP 31.10.2006 ————————————————————————— Language: English Issuer: Fresenius Medical Care AG & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Deutschland Phone: +49 (0) 6172- 609 2525 Fax: +49 (0) 6172- 609 2301 E-mail: ir@fmc-ag.com WWW: www.fmc-ag.de ISIN: DE0005785802, DE0005785836, WKN: 578580, 578583 Indices: DAX Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-Bremen, Hannover, München, Hamburg, Düsseldorf, Stuttgart; Terminbörse EUREX; Foreign Exchange(s) NYSE End of News DGAP News-Service —————————————————————————